Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Net Margin (2018 - 2025)

AVITA Medical's Net Margin history spans 8 years, with the latest figure at 12.63% for Q4 2025.

  • For Q4 2025, Net Margin fell 28531.0% year-over-year to 12.63%; the TTM value through Dec 2025 reached 33.36%, down 3326.0%, while the annual FY2025 figure was 67.85%, 6775.0% down from the prior year.
  • Net Margin reached 12.63% in Q4 2025 per RCEL's latest filing, up from 78.04% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 272.68% in Q4 2024 to a low of 168.03% in Q1 2024.
  • Average Net Margin over 5 years is 41.75%, with a median of 74.86% recorded in 2025.
  • Peak YoY movement for Net Margin: skyrocketed 32311bps in 2023, then tumbled -28531bps in 2025.
  • A 5-year view of Net Margin shows it stood at 84.73% in 2021, then skyrocketed by 31bps to 58.04% in 2022, then skyrocketed by 557bps to 265.07% in 2023, then increased by 3bps to 272.68% in 2024, then crashed by -105bps to 12.63% in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Net Margin are 12.63% (Q4 2025), 78.04% (Q3 2025), and 54.43% (Q2 2025).